Delivery Order SPE2DB20D1047-SPE2DB23FF72F
Award Date 6/26/23
Potential Completion Date 6/27/23
Potential Value $914
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,944.02 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 60 tablets of Briviact, a 25 milligram anti-seizure medication. The order was placed under an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and various Department of Defense customers. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with delivery required...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.75 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units). This firm fixed-price contract, awarded on December 30, 2025, with an ultimate completion date of December 31, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,690 to Amerisourcebergen Drug Corporation to provide 50mg Briviact tablets. The order is for 60 tablets to be delivered to a location in Conshohocken, Pennsylvania by September 22, 2023. Amerisourcebergen Drug Corporation will perform as the prime contractor, with its parent company listed as Amerisourcebergen Corporation. The Defense Logistics Agency routinely issues such orders under existing...
- The Defense Logistics Agency awarded a $2,786.04 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Briviact 100 mg, with an ultimate completion date of October 20, 2025. This is a firm fixed price, non-competitive delivery order that serves the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, with extensive experience...
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency Troop Support Medical awarded a $827.72 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 60 tablets of the 100 mg Briviact medication. This order was placed under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and the Department of Defense. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania by the scheduled completion date of June...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Briviact 50 mg tablets (60-count units) with a ceiling value of $3,639.16. This is a firm fixed-price delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle valued through December 2026. The award was competitively granted with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $2,004.05 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) on November 18, 2025, with completion expected by November 19, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $1,624.15 to AmerisourceBergen Drug Corp for Briviact 75 mg tablets (60-count units) on July 22, 2025, with completion scheduled for July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,451.23 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Briviact 50 mg tablets (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB23FF72FDelivery Order
The Defense Logistics Agency awarded a $913.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 50 mg Briviact tablets. Under this single award, Amerisourcebergen will deliver 60 tablets to a facility in Conshohocken, Pennsylvania by June 27, 2023 to support the DLA's medical supply needs. As a top 10 Defense Department contractor, Amerisourcebergen frequently provides pharmaceuticals and medical supplies to DLA under the agency's Prime Vendor Next contract vehicle. No subcontractors or set aside designations were identified for this short-term order fulfilling critical product requirements.
Generated 12/24/23, 5:47 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $914 | 6/26/23 |